MitoRx Therapeutics
Oxford, United Kingdom · Biotechnology, Health Care, Therapeutics
MitoRx Therapeutics is a pre-clinical stage rare disease biotech company aiming to become the leading global developer of medicines arresting the progression of degenerative diseases driven by mitochondrial dysfunction, with a focus on neuromuscular disease, metabolic disease and neurodegenerative disease.
Key facts
- Headquarters
- Oxford, United Kingdom
- Employees
- 13
- Industries
- Biotechnology, Health Care, Therapeutics
- Status
- Private
- Website
- mitorxtherapeutics.com
- Company page
Recent activity at MitoRx Therapeutics
- : MitoRx Appoints Alison Strutt as Chief Financial Officer and László Tankó as Chief Marketing Officer
- : MitoRx Therapeutics raises £5.5m in a pre-Series A funding round led by Oshen Holdings to advance its obesity therapy Myo-004.
- : MitoRx Therapeutics Appoints Dr. Lubor Gaal as Chief Business Officer and Stacey Massey as Finance Director
- : Mitorx Therapeutics Announces Seed Financing To Advance Its Mitochondrial-Protective Therapeutics To Treat Degenerative Diseases
MitoRx Therapeutics funding history
| Date | Round | Amount |
|---|---|---|
| Nov 2025 | Pre-Series A | $5.5M |
| Apr 2022 | Seed | Undisclosed |
Leadership
- László Tankó, Chief Marketing Officer
- Alison Strutt, Chief Financial Officer
- Jon Rees, Founder
- Norman Law, Founder
- Stacey Massey, Finance Director
- Lubor Gaal, Chief Business Officer
Verified email and direct lines for MitoRx Therapeutics’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
MitoRx Therapeutics in the news
Companies similar to MitoRx Therapeutics
- Eloxx Pharmaceuticals · Biotechnology, Health Care, Therapeutics
- Junevity · Biotechnology, Health Care, Therapeutics
- TNF Pharmaceuticals · Biotechnology, Health Care, Therapeutics
- LTR Pharma Limited · Biotechnology, Health Care, Therapeutics
- Privo Technologies · Biotechnology, Health Care, Therapeutics
About MitoRx Therapeutics: questions and answers
What does MitoRx Therapeutics do?
MitoRx Therapeutics is a pre-clinical stage rare disease biotech company aiming to become the leading global developer of medicines arresting the progression of degenerative diseases driven by mitochondrial dysfunction, with a focus on neuromuscular disease, metabolic disease and neurodegenerative disease.
Where is MitoRx Therapeutics headquartered?
MitoRx Therapeutics is headquartered in Oxford, United Kingdom.
How many employees does MitoRx Therapeutics have?
MitoRx Therapeutics has about 13 employees.
Has MitoRx Therapeutics raised funding?
Yes. Fundz has recorded 2 funding events for MitoRx Therapeutics. The most recent, Pre-Series A of $5.5M, was in Nov 2025.
Who leads MitoRx Therapeutics?
Jon Rees is a Founder at MitoRx Therapeutics.
What is the latest news on MitoRx Therapeutics?
On Jun 09, 2026, MitoRx Appoints Alison Strutt as Chief Financial Officer and László Tankó as Chief Marketing Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy